INTRODUCTION
Over the last decades, DNA-binding low molecular weight compounds have found considerable application as chemotherapeutic agents. On a molecular basis, their cytotoxic effect originates from their interaction with the DNA double helix, often in a non-covalent way. This type of.reversible interaction takes place in three primary ways/1/: (i) surface binding which is generally non-specific and primarily electrostatic in origin e.g. in the case of multiple charged simple cations such as magnesium and cations of simple organic amines/1/, (ii) groove binding interactions e.g. netropsin/2/, distamycin/3/, Hoechst 33258/4/and SN 6999 /5/, and (iii) intercalation of a planar or approximately planar aromatic ring system between base pairs as in the case of ethidium/6/, adriamycin /7/ and daunomycin/8/.
There is increasing interest in the chemical design of small molecular mimics of DNA-binding proteins Major and minor grooves differ significantly in electrostatic potential, hydrogen bond characteristics, steric effects and hydration. Therefore, many proteins exhibit binding specificity primarily through major groove interactions while small groove binding molecules like netropsin and distamycin generally prefer the minor groove of DNA /1/. Unlike the other non-intercalative molecules, A-[Ru(bpy)z(m-GHK)] 2+ forms specific contacts with the walls of the major groove of DNA. This can be partially interpreted by the tendency of the bpy ligand to align itself close to the basepairs /2 8/, a fact already seen in the significant shifts of the aromatic bpy protons. This alignment is probably hindered in the case of the A-isomer where the bpy ligands do not participate in DNA binding, whereas the enantiomer binds from the minor groove. 
